Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 20,550
+1,570 (8.27%)
May 21, 2026, 1:40 PM KST
Onconic Therapeutics Company Description
Onconic Therapeutics, Inc. is a biopharmaceutical company.
It engages in the research and development of new drugs in the field of acid-related diseases and anti cancer.
The company was founded on May 7, 2020 and is headquartered in Seoul, South Korea.
Onconic Therapeutics Inc.
| Country | South Korea |
| Founded | 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | John Kim |
Contact Details
Address: 12 Teheranro-26-gil Seoul South Korea | |
| Phone | 82 2 3454 0780 |
Stock Details
| Ticker Symbol | 476060 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7476060009 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| John Kim | Chief Executive Officer |
| Jongkil Shin | Chief Financial Officer |